pharmacopsychiatry
130595
EN
DE
Home
Produkte
Zeitschriften
Bücher
Buchreihen
Service
Service für Bibliotheken
Hilfe
Kontakt
Portal
Pharmacopsychiatry
Volltextsuche
Volltextsuche
Autorensuche
Titelsuche
DOI-Suche
Metadatensuche
Zeitschrift
Über diese Zeitschrift
Herausgeber
Informationen zur DFG-Nationallizenz
Impressum
X
Autor*innen
Autorenhinweise
Manuskript einreichen
Abonnement
Ihr Abonnement: Kontakt & Information
Lizenzen: Kontaktpartner Institutionen
AGNP
Offizielles Organ der Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie
Collections
Pharmacopsychiatry Women
About Women in Medicine
Open Access
nicht eingeloggt
Login
Benutzername oder E-Mail-Adresse:
Passwort:
Zugangsdaten vergessen?
Neu registrieren
OpenAthens/Shibboleth Login
Warenkorb
Jahre (Archiv)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
Ausgaben
Aktuelle Ausgabe
Kostenlose Probeausgabe (01/2024)
Ähnliche Zeitschriften
Drug Research
Planta Medica
PiD - Psychotherapie im Dialog
Bücher zum Thema
Psychiatrie, Psychotherapie, Psychosomatik
25th Symposium of the AGNP
Abstracts (HTML)
Autorenliste
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
W
X
Y
Z
Rafael, J.
Expressing emotions: Avp and Crh are involved in the phenotype of mice bred for extremes in anxiety-related behavior
Rammes, G.
Functional Consequences of the accumulation of psychopharmacological drugs in „lipid rafts“ on ligand-gated ion channels
Ramsey, J. L.
Atomoxetine treatment of adults with ADHD and comorbid alcohol abuse disorder
Rao, M. L.
Systematic TDM of antidepressants in psychiatric inpatients under naturalistic conditions
Rathgeb-Fuetsch, M.
Long-term efficacy of cognitive-behavioral therapy of patients with anxiety disorders in a hospital setting – influence of continuing psychotherapy and pharmacotherapy
Refojo, D.
Comparison of gene expression patterns in murine blood and brain after chronic paroxetine treatment
Conditional overexpression of corticotropin-releasing hormone – an animal model for understanding the development of corticotropin-releasing hormone-mediated brain pathology
Regenthal, R.
Dopaminergic modulation of manipulation processes in human working memory – critical involvement of D2 receptors and the ventral striatum
Reichel, M.
Prediction of functional inhibition of acid sphingomyelinase and acid ceramidase
Reicherzer, M.
The Loudness Dependence of Auditory Evoked Potentials in patients with borderline personality disorder and healthy control subjects
[123I] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects
Reichwald, U.
Effects of the NMDA receptor antagonist ketamine on stress hormone system regulation, cognitive functioning and posttraumatic stress symptomatology in accident victims
Reif, A.
GIRK2 – A novel candidate gene for attention deficit hyperactivity disorder
Reimold, M.
Reduced thalamic serotonin transporter availability in patients with major depression
Rein, T.
Proteomic search for intrcellular binding sites of antidepressants
Differential effects of TPR proteins on steroid receptor signaling
The hsp70 cochaperones BAG-1M and HspBP1 as possible cause for glucocorticoid resistance
Analysis of gene expression and regulation of a novel, stress-inducible transcript in the mouse
Functional Consequences of the accumulation of psychopharmacological drugs in „lipid rafts“ on ligand-gated ion channels
Epigenetic regulation of the human EAAT2 gene expression in glioma cells and normal brain
Reinecker, H.
Time course of perception in facial expression of emotion in Borderline Personality Disorder (BPD): a Magnetoencephalographic (MEG) study
Reinhold, T.
Algorithm-guided treatment of depression reduces treatment costs – Results from the German Algorithm Project
Reischl, G.
Reduced thalamic serotonin transporter availability in patients with major depression
Reiser, M.
In-vivo topography of structural alterations of the anterior cingulate gyrus in schizophrenia
Reith, W.
Schizophrenia patients present aberrant brain activation patterns during verbal and spatial working memory tasks: an fMRI study
5-HTTLPR polymorphism influences amygdala volume
Renard, D.
Atomoxetine treatment of adults with ADHD and comorbid alcohol abuse disorder
Renner, T. J.
GIRK2 – A novel candidate gene for attention deficit hyperactivity disorder
Reppermund, S.
Susceptibility gene hunting for recurrent unipolar depression using 400k genome-wide genotype data
Polymorphisms in the Leptin Gene are Associated with Resistance to Antidepressant Treatment and Lower Cognitive Performance in Depression
Rettenbacher, M. A.
Drug attitude during the initial treatment period: A prospective follow-up study in patients with schizophrenia
Facial emotion recognition and its relationship to symptomatic, subjective, and functional outcomes in outpatients with chronic schizophrenia
Neutropenia induced by second generation antipsychotics: a prospective investigation
Rhein, V.
Mitochondrial failure in a transgenic mice model of Alzheimer's disease with plaques and tangles
Ribbe, K.
Prediction of outcome by multimodal monitoring of treatment processes in alcoholism therapy
Richter, C.
Efficacy and safety of levetiracetam in the inpatient treatment of alcohol withdrawal syndrome
Richter, D.
Obesity due to psychotropic drugs – a multidisciplinary treatment approach
Ricken, R.
Algorithm-guided treatment of depression reduces treatment costs – Results from the German Algorithm Project
Medical decision making in the treatment of depression – results from the german algorithm project
Riecher-Rössler, A.
The role of medication in suicide attempts in Switzerland
Riedel, M.
Low resolution electromagnetic tomography (LORETA) and SSRI response in obsessive-compulsive disorder
Magnetic resonance imaging and event related potentials of performance monitoring in patients with attention deficit hyperactivity disorder
Homer 1 and metabotropic glutamate-receptor 5 polymorphisms are associated with response to treatment in schizophrenic patients
Dopaminergic neurotransmission in patients with schizophrenia, individuals at risk, and healthy controls
Influences of SNAP-25 polymorphisms on cognitive dysfunctions in schizophrenic patients during an atypical antipsychotic treatment
Do data from a large prospective naturalistic study (N=1014, MDD) support the new FDA recommendation concerning antidepressants suicidality risk?
Riederer, P.
Methylphenidate effects on cell growth and maturation in neuronal stem cells
The effect of methylphenidate treatment on the expression of synaptic vesicle proteins in a mouse model for Attention-Deficit/Hyperactivity Disorder
Rieger, M.
The effects of partial sleep deprivation on response inhibition studied by combined functional MRI and EEG
Ripke, S.
SNPs in the NTRK2 gene are associated with age-at-onset of depressive disorder and attempted suicide
Susceptibility gene hunting for recurrent unipolar depression using 400k genome-wide genotype data
SNPs in the NTRK2 gene are associated with depressive disorder
Polymorphisms in the Leptin Gene are Associated with Resistance to Antidepressant Treatment and Lower Cognitive Performance in Depression
Whole genome analysis reveals new potential drug targets as predictors of antidepressant treatment response
A genome-wide association study in patients with panic and anxiety disorders
Polymorphisms in the angiotensin-converting enzyme gene region predict coping styles in healthy adults and depressed patients
Polymorphisms in the angiotensin-converting enzyme gene region predict coping styles in healthy adults and depressed patients
Rizzi, M.
Serotonin serves as maintenance factor in adult neural stem cells mainly via the 5-HT1A receptor subtype
Robbins, T. W.
Dopaminergic modulation of manipulation processes in human working memory – critical involvement of D2 receptors and the ventral striatum
Robertson-Plouch, C.
Olanzapine versus placebo in adolescent mania
Olanzapine versus placebo in adolescents with schizophrenia
Rockenbach, C.
Rivastigmine reduces smoking – an observational case series
Roemmler, J.
Acromegalic patients: more depressed, without panic? The 'endocrine psychosyndrome' of acromegaly revised
Roesler, M.
Open-label (OL) extension trial of the safety and tolerability of OROS® methylphenidate in adults with ADHD – the long-acting methylphenidate in adult ADHD (LAMDA) trial
Efficacy and safety of OROS® methylphenidate in adults with ADHD: the long-acting methylphenidate in adult ADHD (LAMDA) trial
Romanos, M.
GIRK2 – A novel candidate gene for attention deficit hyperactivity disorder
Röpke, S.
Time course of perception in facial expression of emotion in Borderline Personality Disorder (BPD): a Magnetoencephalographic (MEG) study
Röschke, J.
Systematic TDM of antidepressants in psychiatric inpatients under naturalistic conditions
Röser, C.
GIRK2 – A novel candidate gene for attention deficit hyperactivity disorder
Rossenu, S.
Pharmacokinetics and dopamine d2 and serotonin 5-ht2a receptor occupancy of paliperidone in healthy subjects: two open-label, single-dose studies (PAL-115)
Rossner, M. J.
Phase-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling syndrome
Rothermundt, M.
Quetiapine in the treatment of agitated depression
Preliminary investigations on immune parameters in remitted patients with an affective disorder after amantadine treatment
Rujescu, D.
Serotonin serves as maintenance factor in adult neural stem cells mainly via the 5-HT1A receptor subtype
Differentially expressed genes in an animal model of psychosis associated to schizophrenia within a large case-control study
Members of the forkhead family of transcription factors might be involved in the pathogenesis of schizophrenia
Enhanced cognition in schizophrenics treated with ziprasidone might rely on migration of adult neural stem cells
Genetic association study in schizophrenia and intermediate phenotypes
A study on pharmacogenetics of haloperidol treatment
Forkhead box P (foxP) mRNA expression in the rat hippocampus negatively correlates with performance in a spatial memory paradigm
Creatine mediates neuroprotection towards excitoxicity in an in vitro model of neurodegeneration
Regionally different responses of GABAergic interneuron populations to a NMDA receptor antagonist challenge with MK-801 and an antipsychotic “rescue therapy“ in an animal model of psychosis
Neuropsychological endophenotypes as tools for genetic studies in schizophrenia
Genetics of aggression-related traits as risk factors for suicidal behavior
Ruppert, A.
Differentially expressed genes in an animal model of psychosis associated to schizophrenia within a large case-control study
Members of the forkhead family of transcription factors might be involved in the pathogenesis of schizophrenia
Genetic association study in schizophrenia and intermediate phenotypes
Rupprecht, R.
Whole genome analysis reveals new potential drug targets as predictors of antidepressant treatment response
Association between SNPs in the promoter region of the tryptophan hydroxylase 2 gene (TPH2) and the hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation in patients with major depression
Acute prefrontal rTMS increases striatal dopamine to a similar degree as d-amphetamine
Association between SNPs in the promoter region of the tryptophan hydroxylase 2 gene (TPH2) and the hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation in patients with major depression
Functional Consequences of the accumulation of psychopharmacological drugs in „lipid rafts“ on ligand-gated ion channels
Aripiprazole has both agonistic and antagonistic effects on the dopaminergic system in endocrinological challenge tests
Functional neuroanatomy of CCK-4 induced panic attacks in healthy volunteers
Rüsch, N.
Increased prefrontal and hippocampal glutamate concentration in first episode paranoid-hallucinatory schizophrenia: evidence from a magnetic resonance spectroscopy study